| Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection J Zuo, AC Dowell, H Pearce, K Verma, HM Long, J Begum, F Aiano, ... Nature immunology 22 (5), 620-626, 2021 | 455 | 2021 |
| Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... Nature immunology 23 (1), 40-49, 2022 | 190 | 2022 |
| Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress S Sultana, K Verma, R Khan Journal of Pharmacy and Pharmacology 64 (6), 872-881, 2012 | 125 | 2012 |
| Human CD8+ CD57- TEMRA cells: Too young to be called "old" K Verma, J Ogonek, PR Varanasi, S Luther, I Bünting, K Thomay, ... PLoS One 12 (5), e0177405, 2017 | 111 | 2017 |
| CD117 (c-Kit) Is Expressed During CD8+ T Cell Priming and Stratifies Sensitivity to Apoptosis According to Strength of TCR Engagement G Frumento, J Zuo, K Verma, W Croft, P Ramagiri, FE Chen, P Moss Frontiers in immunology 10, 468, 2019 | 30 | 2019 |
| COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia H Parry, R Bruton, T Roberts, G McIlroy, S Damery, P Sylla, AC Dowell, ... Cancer Cell 40 (6), 584-586, 2022 | 23 | 2022 |
| Homeostatic cytokines drive epigenetic reprogramming of activated T cells into a “naive-memory” phenotype G Frumento, K Verma, W Croft, A White, J Zuo, Z Nagy, S Kissane, ... Iscience 23 (4), 2020 | 23 | 2020 |
| PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity HM Parry, AC Dowell, J Zuo, K Verma, FAM Kinsella, J Begum, W Croft, ... PLoS pathogens 17 (3), e1009349, 2021 | 19 | 2021 |
| Characterization of high-avidity cytomegalovirus-specific T cells with differential tetramer binding coappearing after allogeneic stem cell transplantation J Ogonek, K Verma, C Schultze-Florey, P Varanasi, S Luther, P Schweier, ... The Journal of Immunology 199 (2), 792-805, 2017 | 17 | 2017 |
| Unique features and clinical importance of acute alloreactive immune responses CF Inman, SA Eldershaw, JE Croudace, NJ Davies, A Sharma-Oates, ... JCI insight 3 (10), 2018 | 12 | 2018 |
| Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people H Parry, R Bruton, R Ayodele, P Sylla, G McIlroy, N Logan, S Scott, ... Cell Reports Medicine 3 (9), 2022 | 11 | 2022 |
| Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... | 11 | 2021 |
| miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation K Verma, N Jyotsana, I Buenting, S Luther, A Pfanne, T Thum, A Ganser, ... PLoS One 12 (8), e0183828, 2017 | 11 | 2017 |
| Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations S Eldershaw, K Verma, W Croft, T Rai, FAM Kinsella, C Stephens, H Chen, ... Iscience 24 (3), 2021 | 9 | 2021 |
| Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection G Tut, T Lancaster, MS Butler, P Sylla, E Spalkova, D Bone, N Kaur, ... Nature Aging 2 (6), 536-547, 2022 | 7 | 2022 |
| 2-specific T-cell immunity is maintained at 6 months following primary infection. bioRxiv 2020.11. 01.362319 J Zuo, A Dowell, H Pearce, K Verma, H Long, J Begum, F Aiano, ... | 3 | |
| PD-1 expression contributes to functional impairment of NK cells in patients with B-CLL M Farhat, W Croft, HM Parry, K Verma, FAM Kinsella, J Xu, D Bone, ... Leukemia, 1-5, 2024 | 2 | 2024 |
| Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic SCT is predictive of subsequent relapse and survival K Verma, W Croft, H Pearce, J Zuo, C Stephens, J Nunnick, FAM Kinsella, ... Haematologica, 2022 | 2* | 2022 |
| CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD K Verma, W Croft, S Margielewska-Davies, H Pearce, C Stephens, ... Blood Advances 8 (18), 4900-4912, 2024 | 1 | 2024 |
| Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation K Verma, W Croft, D Greenwood, C Stephens, R Malladi, J Nunnick, J Zuo, ... Frontiers in immunology 14, 1332777, 2024 | 1 | 2024 |
